News Updates

The US Food and Drug Administration (FDA) has approved latanoprostophthalmic emulsion 0.005% (Xelpros, Sun Pharmaceuticals) to reduce elevated intraocular pressure (IOP) in patients with
Clinicians experienced with the newer anesthesia option of MKO Melt (Imprimis Pharmaceuticals, San Diego) say it has important advantages and some limitations. MKO Melt
(Mynosys Cellular Devices, Fremont, California) entered the U.S. market in June 2017, and since then, surgeons have found the automated capsulotomy device provides numerous
Healing of a neurotrophic corneal ulcer in a patient treated with cenegermin, viewed under white light(top row) and with fluorescein staining under cobalt-blue light
Ocutech recently released the VES Falcon Autofocus Bioptic Telescope for low-vision patients. Ocutech says the VESFalcon  is the world’s only autofocusing bioptic for the
Experience with toric IOLs has shown that posterior corneal astigmatism (PCA), if ignored, can throw off the predicted astigmatism correction. Patients with with-the-rule (WTR)